BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25320223)

  • 21. Giant cell arteritis treatment patterns and rates of serious infections.
    Tedeschi SK; Jin Y; Vine S; Lee H; Pethoe-Schramm A; Yau V; Kim SC
    Clin Exp Rheumatol; 2022 May; 40(4):826-833. PubMed ID: 34905480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Detection of Rheumatic Disease through Hospital Diagnoses with Examples of Rheumatoid Arthritis and Giant Cell Arteritis: What Are We Missing?
    John Michet C; Crowson CS; Achenbach SJ; Matteson EL
    J Rheumatol; 2015 Nov; 42(11):2071-4. PubMed ID: 26233503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities.
    Petri H; Nevitt A; Sarsour K; Napalkov P; Collinson N
    Arthritis Care Res (Hoboken); 2015 Mar; 67(3):390-5. PubMed ID: 25132663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.
    Lo Gullo A; Koster MJ; Crowson CS; Makol A; Ytterberg SR; Saitta A; Salvarani C; Matteson EL; Warrington KJ
    PLoS One; 2016; 11(2):e0149579. PubMed ID: 26901431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study.
    Aviña-Zubieta JA; Bhole VM; Amiri N; Sayre EC; Choi HK
    Ann Rheum Dis; 2016 Jan; 75(1):148-54. PubMed ID: 25265937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignancy risk in patients with giant cell arteritis: a population-based cohort study.
    Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Gabriel SE; Ytterberg SR; Matteson EL; Warrington KJ
    Arthritis Care Res (Hoboken); 2010 Feb; 62(2):149-54. PubMed ID: 20191512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Cancer in 767 Patients with Giant Cell Arteritis in Western Norway: A Retrospective Cohort with Matched Controls.
    Brekke LK; Fevang BS; Diamantopoulos AP; Assmus J; Esperø E; Gjesdal CG
    J Rheumatol; 2020 May; 47(5):722-729. PubMed ID: 31308209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica or giant cell arteritis: a cohort study in England.
    Wu J; Keeley A; Mallen C; Morgan AW; Pujades-Rodriguez M
    CMAJ; 2019 Jun; 191(25):E680-E688. PubMed ID: 31235489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Giant cell arteritis: A nationwide, population-based cohort study on incidence, diagnostic imaging, and glucocorticoid treatment.
    Therkildsen P; de Thurah A; Hansen IT; Nørgaard M; Nielsen BD; Hauge EM
    Semin Arthritis Rheum; 2021 Apr; 51(2):360-366. PubMed ID: 33601192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of thoracic aortic complications among patients with giant cell arteritis: a nationwide, population-based cohort study.
    Therkildsen P; de Thurah A; Nielsen BD; Hansen IT; Eldrup N; Nørgaard M; Hauge EM
    Rheumatology (Oxford); 2022 Jul; 61(7):2931-2941. PubMed ID: 34918058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
    Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
    Semin Arthritis Rheum; 2017 Jun; 46(6):819-827. PubMed ID: 28040244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal Trends of Venous Thromboembolism Risk Before and After Diagnosis of Giant Cell Arteritis.
    Unizony S; Lu N; Tomasson G; Zhang Y; Merkel PA; Stone JH; Antonio Aviña-Zubieta J; Choi HK
    Arthritis Rheumatol; 2017 Jan; 69(1):176-184. PubMed ID: 28029234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer preceding giant cell arteritis: a case-control study.
    Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Ytterberg SR; Matteson EL; Gabriel SE; Warrington KJ
    Arthritis Rheum; 2010 Jun; 62(6):1763-9. PubMed ID: 20191583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reappraisal of large artery involvement in giant cell arteritis: a population-based cohort over 70 years.
    Elfishawi MM; Kaymakci MS; J Achenbach S; S Crowson C; Kermani TA; M Weyand C; J Koster M; Warrington KJ
    RMD Open; 2024 Feb; 10(1):. PubMed ID: 38331471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Diabetes Mellitus among Patients Diagnosed with Giant Cell Arteritis or Granulomatosis with Polyangiitis: Comparison with the General Population.
    Faurschou M; Ahlström MG; Lindhardsen J; Obel N; Baslund B
    J Rheumatol; 2017 Jan; 44(1):78-83. PubMed ID: 27744394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations.
    Unizony S; McCulley TJ; Spiera R; Pei J; Sidiropoulos PN; Best JH; Birchwood C; Pavlov A; Stone JH
    Arthritis Res Ther; 2021 Jan; 23(1):8. PubMed ID: 33407817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.
    Li L; Neogi T; Jick S
    Rheumatology (Oxford); 2017 May; 56(5):753-762. PubMed ID: 28077689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk of cardiovascular disease in giant cell arteritis: a general population-based study.
    Amiri N; De Vera M; Choi HK; Sayre EC; Avina-Zubieta JA
    Rheumatology (Oxford); 2016 Jan; 55(1):33-40. PubMed ID: 26248811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period.
    Catanoso M; Macchioni P; Boiardi L; Muratore F; Restuccia G; Cavazza A; Pipitone N; Mancuso P; Luberto F; Salvarani C
    Arthritis Care Res (Hoboken); 2017 Mar; 69(3):430-438. PubMed ID: 27214746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study.
    Moreno-Torres V; Soriano V; Calderón-Parra J; Martínez-Urbistondo M; Treviño A; de San Vicente Z; de Mendoza C; Ruiz-Irastorza G
    Autoimmun Rev; 2023 Jun; 22(6):103341. PubMed ID: 37062441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.